Immedica Pharma sold Immedica Pharma to Immedica Pharma as part of a private equity on 2024-04-23.
Deal value was 11000000000 (source: AI Estimation) Seller position: equal ownership (post-closing partnership); Sector: Pharmaceuticals; Location: Europe.
On the seller side, Latham & Watkins advised, led by Robbie McLaren.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Latham & Watkins advises Impilo on sale of Immedica Pharma to KKR | The Sponsor - The Sponsor
